niacin has been researched along with Cerebral Arteriosclerosis in 16 studies
Niacin: A water-soluble vitamin of the B complex occurring in various animal and plant tissues. It is required by the body for the formation of coenzymes NAD and NADP. It has PELLAGRA-curative, vasodilating, and antilipemic properties.
vitamin B3 : Any member of a group of vitamers that belong to the chemical structural class called pyridines that exhibit biological activity against vitamin B3 deficiency. Vitamin B3 deficiency causes a condition known as pellagra whose symptoms include depression, dermatitis and diarrhea. The vitamers include nicotinic acid and nicotinamide (and their ionized and salt forms).
nicotinic acid : A pyridinemonocarboxylic acid that is pyridine in which the hydrogen at position 3 is replaced by a carboxy group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Stroke is an uncommon disease in childhood with an estimated incidence of 1 to 6 per 100,000 and stenoocclusive arteriopathy is the main risk factor of recurrent pediatric arterial ischemic stroke (AIS)." | 1.46 | Elevated serum lipoprotein(a) as a risk factor for combined intracranial and extracranial artery stenosis in a child with arterial ischemic stroke: A case report. ( Han, JY; Kim, HJ; Lee, IG; Park, J; Shin, S, 2017) |
| "Niaspan treatment of stroke increases vascular stabilization, decreases brain hemorrhage and blood-brain-barrier (BBB) leakage in T1DM rats." | 1.39 | Niaspan attenuates the adverse effects of bone marrow stromal cell treatment of stroke in type one diabetic rats. ( Chen, J; Chopp, M; Lu, M; Ning, R; Roberts, C; Venkat, P; Yan, T; Ye, X; Zacharek, A, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (81.25) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (6.25) | 29.6817 |
| 2010's | 2 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Han, JY | 1 |
| Kim, HJ | 1 |
| Shin, S | 1 |
| Park, J | 1 |
| Lee, IG | 1 |
| Yan, T | 1 |
| Ye, X | 1 |
| Chopp, M | 1 |
| Zacharek, A | 1 |
| Ning, R | 1 |
| Venkat, P | 1 |
| Roberts, C | 1 |
| Lu, M | 1 |
| Chen, J | 1 |
| THOMPSON, LJ | 1 |
| PROCTOR, RC | 1 |
| O'REILLY, PO | 1 |
| KEOGH, RP | 1 |
| KESSENS, L | 1 |
| CURRAN, TR | 1 |
| PHELPS, DK | 1 |
| GRUVSTAD, M | 1 |
| BJURWILL, B | 1 |
| STERN, FH | 1 |
| FERNANDEZBLANCO, E | 1 |
| DEFERNANDEZBLANCO, JF | 1 |
| AGUSTINARZENO, J | 1 |
| MUSTARD, DM | 1 |
| KUNERT, W | 1 |
| DUNKER, R | 1 |
| DUCHENE, W | 1 |
| LAWRENCE, RM | 1 |
| LEICHMAN, NS | 1 |
| DANEMAN, EA | 1 |
| CHORNESKY, G | 1 |
| HAYCOX, JA | 1 |
| Taylor, AJ | 1 |
| Lee, HJ | 1 |
| Sullenberger, LE | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| ARBITER 6: ARterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol 6 - HDL and LDL Treatment Strategies in Atherosclerosis (HALTS)[NCT00397657] | Phase 4 | 400 participants (Anticipated) | Interventional | 2006-11-30 | Terminated (stopped due to Independent steering committee has stopped the trial based on results of a prespecified, blinded interim analysis. It was not stopped due to safety concerns.) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for niacin and Cerebral Arteriosclerosis
| Article | Year |
|---|---|
The effect of 24 months of combination statin and extended-release niacin on carotid intima-media thickness: ARBITER 3.
Topics: Aged; Carotid Arteries; Carotid Artery Diseases; Cholesterol, HDL; Delayed-Action Preparations; Drug | 2006 |
15 other studies available for niacin and Cerebral Arteriosclerosis
| Article | Year |
|---|---|
Elevated serum lipoprotein(a) as a risk factor for combined intracranial and extracranial artery stenosis in a child with arterial ischemic stroke: A case report.
Topics: Child; Dyslipidemias; Humans; Intracranial Arteriosclerosis; Lipoprotein(a); Male; Niacin; Risk Fact | 2017 |
Niaspan attenuates the adverse effects of bone marrow stromal cell treatment of stroke in type one diabetic rats.
Topics: Animals; Blood-Brain Barrier; Diabetes Mellitus, Type 1; Disease Models, Animal; Ectodysplasins; Int | 2013 |
The effect of nicotinic acid and pentylenetetrazol in the therapy of psychiatric symptoms of cerebral arteriosclerosis.
Topics: Arteriosclerosis; Humans; Intracranial Arteriosclerosis; Mental Disorders; Niacin; Nicotinic Acids; | 1954 |
Effect of niacin on the electroencephalogram of psychosis with cerebral arteriosclerosis.
Topics: Arteriosclerosis; Cholinergic Agents; Electroencephalography; Intracranial Arteriosclerosis; Niacin; | 1958 |
[On the treatment of cerebral sclerosis with complamine].
Topics: Intracranial Arteriosclerosis; Niacin; Nicotinic Acids; Theophylline; Tuberous Sclerosis; Xanthinol | 1960 |
Sustained release pentylenetetrazol-nicotinic acid therapy in senile patients.
Topics: Delayed-Action Preparations; Humans; Intracranial Arteriosclerosis; Niacin; Nicotinic Acids; Patient | 1960 |
[On Cosaldin and psychic functions in the elderly. Criticism of the method used in a psychopharmacological study].
Topics: Concept Formation; Geriatrics; Intracranial Arteriosclerosis; Memory; Niacin; Nicotinic Acids; Orien | 1963 |
[Effect of Cosaldin the capacity for orientation, memory and thinking in elderly patients with cerebral arteriosclerosis].
Topics: Aged; Humans; Intracranial Arteriosclerosis; Memory; Niacin; Nicotinic Acids; Theobromine; Thinking | 1963 |
COMPARISON OF THREE AGENTS (TIGACOL, DRAMAMINE AND ANTIVERT) FOR THE CONTROL OF DIZZINESS IN GERIATRIC PATIENTS.
Topics: Alcohols; Benzamides; Cochlear Nerve; Dimenhydrinate; Dizziness; Geriatrics; Humans; Intracranial Ar | 1963 |
[7-(3-(METHYL-OXYETHYLAMINE)-2-OXYPROPYL)-1, 3-DIMETHYL-XANTHINE NICOTINATE IN CHRONIC OBLITERATING ANGIOPATHIES].
Topics: Arteriosclerosis; Arteriosclerosis Obliterans; Cholesterol; Coronary Disease; Humans; Intracranial A | 1963 |
TREATMENT OF PARKINSONISM IN ELDERLY PATIENTS WITH COSALDON.
Topics: Cerebrovascular Circulation; Drug Combinations; Drug Therapy; Geriatrics; Intracranial Arteriosclero | 1964 |
[ON ELECTRORHEOGRAPHIC OBJECTIVE EVALUATION OF SUBSTANCES WITH CENTRAL NERVOUS SYSTEM ACTION. SODIUM NICOTINATE AND SODIUM BETA,BETA-PENTAMETHYLENE-GAMMA-HYDROXYBUTYRATE MONOHYDRATE].
Topics: 3-Hydroxybutyric Acid; Cerebrovascular Circulation; Dementia; Drug Therapy; Electric Impedance; Elec | 1963 |
[REPORT ON THE SUBJECT OF RESULTS OBTAINED WITH COSALDON TREATMENT IN 35 PATIENTS OF THE INSTITUT NOTRE-DAME AT BRUGES-ST. MICHEL DURING THE PERIOD FROM JUNE TO DECEMBER, 1963].
Topics: Belgium; Drug Combinations; Drug Therapy; Enkephalin, Methionine; Geriatrics; Hallucinations; Humans | 1964 |
COMPARISON OF THE EFFECTS OF HEPARIN SODIUM, XANTHINOL NIACINATE (COMPLAMIN) AND 2-DIMETHYL-AMINOETHANOL (DEANER) IN INSTITUTIONALIZED GERIATRIC GROUPS.
Topics: Antidepressive Agents; Behavior; Biomedical Research; Cerebrovascular Disorders; Deanol; Depression; | 1965 |
Psychosomatic investigations of cerebral arteriosclerosis with psychosis.
Topics: Arteriosclerosis; Humans; Intracranial Arteriosclerosis; Niacin; Nicotinic Acids; Psychosomatic Medi | 1955 |